Adamax vs Semax: differences, evidence and safety

Answer first

Semax is a chain of seven amino acids copied from a fragment of the hormone ACTH, and a prescription medicine in Russia. Adamax is sold as Semax with an added carbon cage called adamantane. Six database searches found no study of it, and its structure is unsettled. No study comparing the two could be found, so neither can be ranked.

At a glance

How they work

Semax is a synthetic chain of seven amino acids. Four of them reproduce a fragment of ACTH, the pituitary hormone that tells the adrenal glands to make steroids. The last three, proline, glycine and proline, were added on purpose to slow the enzymes that break peptides apart ^[1].

• No hormone action. In side-by-side laboratory comparisons, ACTH fragments made adrenal cells produce steroids, while Semax did not ^[2].
• No known target. The FDA review of May 2026 states that Semax acts through poorly understood mechanisms and that no molecular target has been identified ^[1].
• Nerve growth factors in rats. The most reproduced finding is a rise in two proteins that help nerve cells survive, BDNF and NGF, in rat brain tissue. No study showing it in a person could be found ^[3], ^[4], ^[5].
• A dopamine caveat. In mice, Semax increased amphetamine-driven dopamine release, a pattern the FDA calls concerning because it resembles drugs of abuse ^[1].

Adamax has no measured mechanism, because no measurement of it could be found ^[11]. The name is a seller's coinage: "Ada-" from adamantane, a cage-shaped carbon structure, and "-max" from maximal ^[6]. Sellers make four main claims, and each one borrows from another substance.

• "It is Semax that lasts longer." Blocking both ends of a peptide chain does slow its breakdown, and that has been examined for acetylated Semax ^[7]. No such examination of Adamax could be found ^[11].
• "The adamantane part carries it into the brain." This was published for a different peptide, P021, in mice. P021 has another sequence and says nothing about Adamax ^[8].
• "It releases amantadine in the body." This appears in a shop's own text, phrased as a possibility. No metabolism experiment stands behind it ^[6].
• "It raises BDNF." This comes from a scene article, and no measurement for Adamax could be found. It is a Semax finding transferred to a different molecule ^[9].

The core difference is therefore not a receptor or a pathway. Semax has a mechanism that is poorly understood but studied in animals and cells. Adamax has only reasoning by analogy, and even that rests on a structure that could not be confirmed ^[10].

Small changes to a peptide alter how it binds, how quickly it breaks down and where it ends up in the body. So findings about Semax say nothing about Adamax, even if the sellers' description of the molecule were correct.

What the studies show

Studies that compared Adamax and Semax

No study that compares Adamax and Semax directly could be found in the published record reviewed for this page. There is a simpler reason than usual. Six database searches found no study of Adamax on its own either, in people, in animals or in cells ^[11], ^[15].

Adamax: what the searches found

No studies Six literature and substance databases were searched on 6 September 2026: PubMed, Europe PMC, Crossref, PubChem, ClinicalTrials.gov and Google Patents. None of them holds anything about the substance ^[11], ^[12], ^[13], ^[14], ^[15], ^[16].

Each search ran with a control that was known to work. PubMed returns 39 records for the word Adamax, and all 39 were opened individually. Every one is about Adamax as a variant of the Adam optimiser, a method used to train machine-learning models ^[11].

The control search for the plain term Semax, in the same query run, returned 231 records. PubChem resolved Semax normally in the same session, while seven spellings of Adamax all came back as not found ^[11], ^[14]. The empty result is therefore not a fault in the search.

The sellers say much the same. The person credited with creating Adamax is quoted as saying it was made with no clinical research "or any research of any kind". A Russian shop writes that it remains uninvestigated ^[6], ^[9].

Where the Adamax claims come from

Borrowed evidence Two published lines of work are regularly cited as though they were about Adamax. The P021 papers describe a different peptide with a different sequence ^[8]. The Semax stability work concerns acetylated Semax, not an adamantane-bearing molecule ^[7].

Neither line of work tested Adamax. Quoting them as evidence for it means quoting results for other molecules.

Semax: studies in people

The international trials register lists no Semax study. A query of ClinicalTrials.gov on 6 September 2026 returned a total of 0 studies ^[17]. A PubMed search on the same day, limited to titles and abstracts, returned 207 records, only 10 of them classed as reviews ^[18].

Placebo-controlled imaging In 2018, 24 healthy adults were scanned, 14 after Semax and 10 after a dummy treatment. The front part of one resting brain network, the default mode network, came out larger in the Semax group. No clinical outcome was measured, and the study was not registered ^[19].

Unregistered, full text not obtainable The developers' group reported in 1996 that a single nasal dose stimulated working memory and attention in 19 healthy men. The sample was small and male only, and the journal is not indexed in PubMed ^[1], ^[20].

Open, uncontrolled A 1996 pain study covered 37 adults. Among 16 people with trigeminal neuralgia, a stabbing facial nerve pain, nothing changed at all. Among 12 people with migraine, the headache ended in 4 and eased in 8. The authors concluded that Semax shows no pain-relieving activity by itself ^[1], ^[21].

Observational, unregistered The Russian stroke studies form the largest body of human work. A 1997 study compared 30 patients given Semax with 80 on conventional treatment, without randomisation or blinding ^[22]. A 2005 report followed 187 patients with no described control group ^[23].

A 2018 study of 110 stroke patients in rehabilitation found higher blood levels of BDNF in the Semax groups. Those levels moved together with a score of everyday function, which is a correlation rather than proof of cause ^[24]. The FDA did not assess this literature, because no certified translation was supplied ^[1].

Semax: animal work

Animal data Rats were given an experimental stroke. After eight days, the area of dead brain tissue was around 20 percent smaller than in animals given plain water. The FDA's objection is that nearly all such studies used a single fixed dose level, and none measured how much peptide reached the body ^[1].

How far the two records can be compared

They cannot be set against each other. Semax has a thin human record, none of it registered, and a large animal literature. For Adamax no record could be found at all. No measurement could be found behind any claim that one is stronger, longer-lasting or better tolerated than the other ^[1], ^[11], ^[15].

Safety

Neither substance has a real safety record, but the gaps are of a different kind.

Adamax

• No side-effect profile. No study in which anyone took Adamax could be found, so no side effect is on record. The absence of reported harm reflects an absence of looking ^[11], ^[15].
• No settled identity. The same shop gives one sequence in its article and another on its product page ^[6], ^[25].
• A formula that contradicts itself. One product page gives the formula C44H61N11O13S and a mass of 1,032.3 g/mol. That formula works out to 984.1 g/mol, about 48 units lighter, so the two figures cannot describe the same substance ^[10], ^[25].
• What is missing. No animal study, toxicology work, independent chemical analysis or independent data on impurities or real peptide content could be found ^[11], ^[15].

Without a settled identity, no safety statement is possible in either direction. What is in the vial is not established, so what it would do cannot be stated either.

Semax

• One listed side effect. The Russian product information names mild irritation of the nasal lining with prolonged use, without a frequency ^[26].
• Who must not use it, per the label. People with hypersensitivity, acute psychotic states, anxiety conditions or a seizure history, and women who are pregnant or breastfeeding ^[2], ^[26].
• One US report. Through 3 December 2025 the FDA adverse event database held a single report, describing eye pain and burning after nasal drops bought online ^[1].
• Possible bleeding risk. Rat studies found increased clot-dissolving activity, from which the FDA draws a bleeding risk, particularly alongside blood-thinning medicines ^[1].
• Immune reactions untested, per the FDA. The FDA wrote that it could not rule out immune reactions linked to impurities and clumped peptide. This is the reason Semax sits on its safety-risk list ^[1], ^[27].
• No standard safety studies. The FDA review found no published single-dose, repeated-dose, genetic-damage or reproductive study, and no human study of how the body handles the peptide ^[1].

The FDA found too little clinical information to describe a safety profile for Semax at all ^[1]. That assessment concerns Semax only. Adamax does not appear in the FDA meeting documents ^[1].

Why this page lists no doses. Semax is a licensed prescription medicine in Russia, where dosing belongs to the approved label and the prescribing doctor. For Adamax no study could be found, so there is no study dose to report. Figures on sales pages are sales copy, and one Russian page cites three journals that are not in the Crossref journal register ^[13], ^[28].

Legal status

Semax has been registered in Russia since 1994 and has been prescription only since 2003 ^[29]. Both current products were re-registered in 2025 ^[26], ^[30]. It is approved nowhere else, and sits on the FDA list of bulk substances that may present significant safety risks ^[27]. In July 2026 an FDA advisory committee voted 8 to 5 to support compounding it; the vote is not binding ^[31], ^[32]. Adamax is approved in no country, Russia included ^[6], ^[28], ^[33], ^[34]. It is banned in sport at all times under section S0. Semax is not named on the 2026 list, and its status is unclear ^[35], ^[36]. See peptides banned in sport. Facts as checked on 6 September 2026.

Used together?

The myPeptides blend directory lists no product that combines Adamax and Semax. Its only blend with Semax is Selank + Semax, which contains no Adamax.

No study of Adamax and Semax together could be found. The question is also unusual, because Adamax is itself sold as a modified form of Semax. No study of that modification could be found either, so there is no measured basis for any statement about the two in combination ^[11], ^[15].

Frequently asked questions

Which is better, Adamax or Semax?

No study comparing Adamax and Semax could be found, and six database searches returned no study of Adamax on its own either. Semax has a small body of human work, none of it in the international trials register. The best of it is a brain scan in 24 healthy adults. Nothing on the Adamax side could be found to set against it.

Is Adamax or Semax safer?

That cannot be said. Semax has a one-line side-effect list on its Russian label, and the FDA review found no published standard safety testing. No safety data on Adamax could be found, and only the shops selling it state which molecule is in the vial. Missing data on both sides is not evidence of safety for either.

What is the difference between Adamax and Semax?

Semax is a documented peptide with a database record, a Russian approval and a published literature. Adamax is a trade article attributed to a Mexican shop that closed in 2018. Sellers describe it as Semax with an adamantane group attached, but they publish two different sequences for it.

Can Adamax and Semax be taken together?

No study of the two together could be found. The myPeptides blend directory lists no product that combines them. Adamax itself is sold as a modified Semax, and no study of that modification could be found either. This page gives no guidance on use.

Is Adamax stronger than Semax?

No measurement of that could be found. The claim comes from sellers, and no experiment behind it could be found. Six database searches found no study of Adamax in people, animals or cells, so no strength or duration is on record. The ideas behind the claim were borrowed from studies of other molecules.

Is Adamax approved anywhere, like Semax is in Russia?

No. Semax is a prescription medicine in Russia and approved nowhere else. Adamax is approved in no country, including Russia, where it is sold only as a research substance. A Russian approval of Semax does not extend to a different molecule sold under a different name.

Are Adamax and Semax banned in sport?

Adamax is banned at all times under section S0, the catch-all for substances no health authority has approved. Semax is in an unresolved position. Its Russian approval means the catch-all clause does not fit on its wording. A 2025 review from within the anti-doping system places it in an unclear category, however.

Why does PubMed show 39 hits for Adamax but hundreds for Semax?

Adamax is also the name of a computing method used to train machine-learning models. All 39 PubMed records were checked, and every one is about that method. The control search for Semax in the same run returned 231 records, so the empty result is real rather than a broken search.

Is Adamax the same as N-acetyl Semax amidate?

No. N-acetyl Semax amidate is a separately recorded compound with both ends of the chain blocked, and it carries no adamantane group. Sellers describe Adamax as that compound with such a group added. Shops often list the two side by side, but the names do not refer to the same molecule.